Production, binding characteristics and protective immunity of monoclonal antibody to pneumococcal type-9V conjugate

Microbiology and Immunology

Volumn 40, Issue 11, 1996, Pages 857-865

  Lee, Chi Jen ^a   Karpas, Arthur ^a   Wang, Theresa R ^a   Kosaka, Tadashi ^a   Koizumi, Kaio ^b  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Monoclonal antibody; Pneumococcal infection; Polysaccharide protein conjugate; Protective immunity

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOLYSIN;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; CELL FUSION; CONJUGATION; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNODIFFUSION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; OPSONIZATION; PASSIVE IMMUNIZATION; PHAGOCYTOSIS; SPLEEN CELL; STREPTOCOCCUS INFECTION;

ANIMALIA; ORYCTOLAGUS CUNICULUS; PNEUMOCOCCUS; STREPTOCOCCUS;

EID: 0030444845     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1996.tb01151.x     Document Type: Article

References (41)

1. Alonso De Velasco, E., Dekker, B.A.T., Verheul, A.F.M., Feldman, R.G., Verhoef, J., and Snippe, H. 1995. Anti-polysaccharide immunoglobulin isotype levels and opsonic activity of antisera: relationships with protection against Streptococcus pneumoniae infection in mice. J. Infect. Dis. 172: 562-565.
2. Armitage, P., and Berry, G. 1994. Statistical inference, p. 93-153. In Statistical methods in medical research, 3 rd ed, Blackwell Scientific Publications, Inc., Cambridge, Mass.
3. Baker, P.J. 1990. Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes. Infect. Immun. 58: 3465-3468.
4. Baker, P.J. 1992. T cell regulation of the antibody response to bacterial polysaccharide antigens: an examination of some general characteristics and their implications. J. Infect. Dis. 165 (Suppl.) 1:S44-S48.
5. Baker, P.J., Amsbaug, D.F., Stashak, P.W., Caldes, G., and Prescott, R. 1981. Regulation of the antibody response to the pneumococcal polysaccharide by thymus-derived cells. Rev. Infect. Dis. 3: 332-341.
6. Baltimore, R.S., Kasper, D.L., Baker, C.J., and Goroff, D.K. 1977. Antigenic specificity of opsonophagocytic antibodies in rabbit antisera to group B streptococci. J. Immunol. 118: 673-678.
7. Bishop, C.T., and Bennet, L.G. 1980. Structure of the type XXXIII Streptococcus pneumoniae (pneumococcus) capsular polysaccharide. Can. J. Chem. 58: 2724-2727.
8. Bruyn, G.A.W., Zegers, B.J.M., and Van Furth, R. 1992. Mechanisms of host defense against infection with Streptococcus pneumoniae. Clin. Infect. Dis. 14: 251-262.
9. Butler, J.C., Breiman, R.F., Lipman, H.B., Hofmann, J., and Facklam, R.R. 1995. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J. Infect. Dis. 171: 885-889.
10. Fairchild, R.L., and Braley-Mullen, H. 1983. Characterization of the murine immune response to type 6 pneumococcal polysaccharide. Infect. Immun. 39: 615-622.
11. Fairchild, R.L., Sterner, K.E., and Braley-Mullen, H. 1986. Primary murine immunoglobin M responses to certain pneumococcal capsular polysaccharides consist primarily of anti-pneumococcal cell wall carbohydrate antibodies. Infect. Immun. 52: 867-871.
12. Frank, M.M. 1987. Current concepts: complement in the pathophysiology of human disease. New Engl. J. Med. 316: 1525-1530.
13. Hassid, W.Z., and Abraham, S. 1957. Chemical procedures for analysis of polysaccharides, p. 34-50. In Colowick, S.P., and Kaplan, N.O. (eds), Methods enzymol, Academic Press Inc., New York, N.Y.
14. Henrichsen, H. 1979. The pneumococcal typing system and pneumococcal surveillance. J. Infect. 1 (Suppl. 2): 31-37.
15. Hestrin, S. 1949. The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine, and its analytical application. J. Biol. Chem. 180: 249-261.
16. Jones, C., Mulloy, B., Wilson, A., Dell, A., and Oates, J.E. 1985. Structure of the capsular polysaccharide from Streptococcus pneumoniae type 9. J. Chem. Soc. Perkin Trans. 1: 1665-1673.
17. Kohler, E., and Milstein, C. 1975. Continuous cultures of fused cells secreting antibodies of predefined specificity. Nature 256: 495-498.
18. Lee, C.J. 1983. The quantitative immunochemical determination of pneumococcal and meningococcal capsular polysaccharides by light scattering rate nephelometry. J. Biol. Stand. 11: 55-64.
19. Lee, C.J., Banks, S.D., and Li, J.P. 1991. Virulence, immunity, and vaccine related to Streptococcus pneumoniae. Crit. Rev. Microbiol. 18(2): 89-114.
20. Lee, C.J., Ching, E.D., and Vickers, J.H. 1991. Maternal immunity and antibody response of neonatal mice to pneumococcal 19F polysaccharide. J. Clin. Microbiol. 29: 1904-1909,
21. Lee, C.J., and Koizumi, K. 1981. Immunochemical relations between pneumococcal group 19 and Klebsiella capsular polysaccharides. J. Immunol. 127: 1619-1623.
22. Lee, C.J., and Lin, K.T. 1981. Studies on vaccine control and immunogenicity of polysaccharides of Streptococcus pneumoniae. Rev. Infect. Dis. 3 (Suppl.): S51-S59.
23. Lee, C.J., Lock, R.A., Andrew, P.W., Mitchell, T.J., Hansman, D., and Paton, J.C. 1994. Protection of infant mice from challenge with Streptococcus pneumoniae type 19F by immunization with a type 19F polysaccharide-pneumolysoid conjugate. Vaccine 12: 875-878.
24. Lee, C.J., Muller, J., Nguyen, N.Y., Paton, J.C., Bank, S.D., Tai, S.S., and Wang, T.R. 1993. Immunity and gene of pneumococcal cell surface antigens. Symposium Med. Sci., Coll. Med., Nat. Taiwan Univ., Taipei, Taiwan, 125-143.
25. Lee, C.J., and Wang, T.R. 1994. Pneumococcal infection and immunization in children. Crit. Rev. Microbiol. 20 (1): 1-12.
26. Liu, T.Y., and Gotschlich, E.C. 1963. The chemical composition of pneumococcal C-polysaccharide. J. Biol. Chem. 238: 1928-1934.
27. Lu, C.H., Hugh, R., and Lee, C.J. 1987. Characterization of the binding of and the immune response to pneumococcal group 9 capsular polysaccharides. Mol. Immunol. 24: 427-433.
28. Lu, C.H., Lee, C.J., and Kinds, P. 1994. Immune responses of young mice to pneumococcal type 9V polysaccharide-tetanus toxoid conjugate. Infect. Immun. 62: 2754-2760.
29. Makoff, L.C., Michel, J.L., Gong, E.W., Rodewald, A.K., and Kasper, D.L. 1992. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein. Infect. Immun. 60: 4989-4994.
30. Musher, D.M., Chapman, A.J., Coree, A., Jonesson, S., Briles, O., and Baughn, R.E. 1986. Natural and vaccine-related immunity to Streptococcus pneumoniae. J. Infect. Dis. 154: 245-256.
31. Perry, M.B., Daoust, V., and Carlo, D.J. 1981. The specific capsular polysaccharide of Streptococcus pneumoniae type 9V. Can. J. Biochem. 59: 524-533.
32. Richards, J.C., and Perry, M.B. 1988. Structure of the specific capsular polysaccharide of Streptococcus pneumoniae type 23F (American type 23). Biochem. Cell Biol. 66: 758-771.
33. Richards, J.C., Perry, M.B., and Kniskern, P.J. 1984. Structural analysis of the specific polysaccharide of Streptococcus pneumoniae type 9L (American type 49). Can. J. Biochem. Cell Biol. 62: 1309-1320.
34. Robbins, J.B., Austrian, R., Lee, C.J., et al. 1983. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within group. J. Infect. Dis. 148: 1136-1159.
35. Schulman, M., Wilde, C.D., and Kohler, G. 1978. A better cell line for making hybridomas secreting specific antibodies. Nature 276: 269-270.
36. Shapiro, E.D., and Austrian, R. 1994. Serotype responsible for invasive Streptococcus pneumoniae infections among children in Connecticut. J. Infect. Dis. 169: 212-214.
37. Sorensen, U.S., Agger, R., Bennedsen, J., and Henrichsen, J. 1984. Phosphorylcholine determinants in six pneumococcal capsular polysaccharides detected by monoclonal antibody. Infect. Immun. 43: 876-878.
38. Szu, S., Lee, C.J., Carlo, D., and Henrichsen, J. 1981. Immunochemical characterization of cross-reactivity of pneumococcal group 9 capsular polysaccharide types 9N, 9A, 9L, and 9V. Infect. Immun. 31: 371-379.
39. Velasco, E.A.D., Verheul, A.F.M., van Steijn, A.M.P., et al. 1994. Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide-and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG. Infect. Immun. 62: 799-808.
40. Verheul, A.F.M., Braat, A.K., Leenhouts, J.M., et al. 1991. Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3, 7, 9 phosphoethanolamine group-containing oligosaccharide-protein conjugates. Infect. Immun. 59: 843-851.
41. Vioarsson, G., Jondottir, I., Jonesson, S., and Valdimarsson, H. 1994. Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae. J. Infect. Dis. 170: 592-599.